ADMA BIOLOGICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ADMA BIOLOGICS, INC. (ADMA) reported Adjustments to Additional Paid in Capital, Warrant Issued of $5.59 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-02-25
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $5.59M.
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2022-03-31 was $9.57M.
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $5.59M, a 41.54% decline from fiscal 2022.
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $9.57M.
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2020 was $3.74M, a 4.52% increase from fiscal 2019.
- ADMA BIOLOGICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2019 was $3.58M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|
| 2023-12-31 | $5.59M 10-K · filed 2026-02-25 | ||||
| 2023-06-30 | $5.59M 10-Q · filed 2024-11-07 | $5.59M 10-Q · filed 2023-08-09 | |||
| 2022-12-31 | $9.57M 10-K · filed 2025-03-18 | $9.57M 10-K · filed 2023-03-23 | |||
| 2022-03-31 | $9.57M 10-Q · filed 2023-11-08 | ||||
| 2020-12-31 | $3.74M 10-K · filed 2022-03-24 | ||||
| 2019-12-31 | $3.58M 10-K · filed 2020-03-13 | ||||
| 2017-12-31 | $614.51K 10-K · filed 2019-03-13 | ||||
| 2015-06-30 | $367.70K 10-Q · filed 2015-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |